CASE NUMBER
8:2024bk80040
8:2024bk80040
TYPE / CHAPTER
Voluntary / 11
Voluntary / 11
Docket Entries by Week of Year
| Apr 1 | 1 | Petition Non-individual Chapter 11 Voluntary Petition. Fee Amount $1738 Filed by Eiger BioPharmaceuticals, Inc. Chapter 11 Plan due by 07/30/2024. Disclosure Statement due by 07/30/2024. (Califano, Thomas) | ||
|---|---|---|---|---|
| Apr 1 | Receipt of filing fee for Voluntary petition (chapter 11)( 24-80040-11) [misc,volp11a] (1738.00). Receipt number A31284451, amount $1738.00 (re: Doc# 1). (U.S. Treasury) | |||
| Apr 1 | 2 | Notice of Appearance and Request for Notice for Innovatus Life Sciences Lending Fund I, LP by Jay Robert Bender Filed by Creditor INNOVATUS LIFE SCIENCES LENDING FUND I, LP. (Bender, Jay) | ||
| Apr 1 | 3 | Motion for joint administration of cases 24-80040 (SGJ); 24-80041 (SGJ); 24-80042 (SGJ); 24-80043 (SGJ); 24-80044 (SGJ) Debtors Emergency Motion for Entry of an Order Directing Joint Administration of Chapter 11 Cases Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: # 1 Exhibit A) (Califano, Thomas) | ||
| Apr 1 | 4 | Motion to maintain bank accounts. Debtors Emergency Motion for Entry of Interim and Final Orders (I) Authorizing the Debtors to Continue to Operate Their Cash Management System and Maintain Existing Bank Accounts (II) Honor Certain Obligations Relating Thereto; and (III) Granting a Waiver of Certain Deposit and Investment Requirements in 11 U.S.C. § 345(B) and the USTGuidelines Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: # 1 Exhibit A # 2 Exhibit B # 3 Exhibit C # 4 Exhibit D) (Califano, Thomas) | ||
| Apr 1 | 5 | Motion regarding utilities. Debtors Emergency Motion for Entry of an Order (I) Approving the Debtors Proposed Adequate Assurance of Payment for Future Utility Services, (II) Prohibiting Utility Companies from Altering, Refusing, or Discontinuing Services, and (III) Approving the Debtors Proposed Procedures for Resolving Additional Assurance Requests Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: # 1 Exhibit A # 2 Exhibit B) (Califano, Thomas) | ||
| Apr 1 | 6 | Motion regarding pre or post petition contracts. Debtors Emergency Motion for Entry of an Order (I) Authorizing the Debtors to (A) Continue Their Prepetition Insurance Coverage and Satisfy Prepetition Obligations Related Thereto and (B) Renew, Supplement, and Enter Into New Insurance Policies, and (II) Granting Related Relief Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: # 1 Exhibit A # 2 Exhibit B) (Califano, Thomas) | ||
| Apr 1 | 7 | Motion to extend time to Debtors Emergency Motion for Entry of an Order Extending Time to File Schedules of Assets and Liabilities and Statements of Financial Affairs Filed by Debtor Eiger BioPharmaceuticals, Inc. Objections due by 4/3/2024. (Attachments: # 1 Exhibit A) (Califano, Thomas) | ||
| Apr 1 | 8 | Motion regarding pre or post petition contracts employee wages/benefits. Debtors Emergency Motion for Entry of an Order (I) Authorizing the Debtors to (A) Pay Prepetition Wages, Salaries, and Employee Benefits and (B) Continue the Postpetition Maintenance of Employee Benefit Programs, Policies, and Procedures in the Ordinary Course Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: # 1 Exhibit A) (Califano, Thomas) | ||
| Apr 1 | 9 | Motion for approval of form notice. Debtors Emergency Motion For Entry of an Order Approving Notification and Hearing Procedures for Certain Transfers of and Declarations of Worthlessness with Respect to Common Stock Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: # 1 Exhibit A) (Califano, Thomas) | ||
| Show 1 more entries Loading... | ||||
| Apr 1 | 11 | Motion to pay tax debts Debtors' Emergency Motion for Entry of Interim and Final Orders Authorizing the Debtors to Pay Certain Taxes and Fees Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: # 1 Exhibit A # 2 Exhibit B # 3 Exhibit C) (Califano, Thomas) | ||
| Apr 1 | 12 | Motion to establish procedures. Debtors Emergency Motion for Entry of an Order (I) Authorizing the Debtors to (A) File a Consolidated Creditor Matrix and (B) File a Consolidated List of 30 Largest Unsecured Creditors; (II) Waiving the Requirement to File a List of Equity Security Holders; (III) Authorizing the Debtors to Redact Certain Personally Identifying Information; and (IV) Approving the Form and Manner of Notifying Creditors of the Commencement of the Chapter 11 Cases and Other Information Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: # 1 Exhibit A) (Califano, Thomas) | ||
| Apr 1 | 13 | Motion to establish procedures bid procedures. Debtors Motion for Entry of an Order (I)(A) Approving the Bid Procedures; (B) Authorizing the Debtors to Select Sentynl Therapeutics, Inc. as the Zokinvy Stalking Horse Purchaser & Approving Bid Protections; (C) Approving the Bid Protections Relating to the Remaining Assets Stalking Horse Purchaser(s), if any; (D) Establishing Bid Deadlines, Auction(s), and Sale Hearing(s); (E) Approving the Form and Manner of Sale Notice; (F) Approving Assignment and Assumption Procedures; (G) Approving the Form and Manner of Potential Assumption and Assignment Notice; (II)(A) Authorizing the Sale of the Assets Free and Clear; and (B) Approving the Assumption and Assignment of Designated Contracts; and (III) Granting Related Relief Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: # 1 Exhibit A) (Califano, Thomas) | ||
| Apr 1 | 14 | Notice of Appearance and Request for Notice by Lawrence James Dickinson filed by Interested Party Sentynl Therapeutics, Inc.. (Dickinson, Lawrence) | ||
| Apr 1 | 15 | Notice of deficiency. Schedule A/B due 4/15/2024. Schedule D due 4/15/2024. Schedule E/F due 4/15/2024. Schedule G due 4/15/2024. Schedule H due 4/15/2024. Declaration Under Penalty of Perjury for Non-individual Debtors due 4/15/2024. Summary of Assets and Liabilities and Certain Statistical Information due 4/15/2024. Declaration for electronic filing within 7 days from the filing of the petition. Statement of Financial Affairs due 4/15/2024. Creditor matrix due 4/3/2024. (Hyden, Kara) | ||
| Apr 1 | 16 | Motion to use cash collateral Debtors' Emergency Motion for Entry of Interim and Final Orders (I) Authorizing the Debtors to Use Cash Collateral; (II) Granting Adequate Protection to Prepetition Term Loan Secured Parties; (III) Modifying Automatic Stay; and (IV) Scheduling a Final Hearing Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: # 1 Proposed Interim Order) (Califano, Thomas) | ||
| Apr 1 | 17 | Motion regarding pre or post petition contracts customers. Debtors Emergency Motion for Entry of Interim and Final Orders (I) Authorizing the Debtors to Honor and Continue Certain Customer Programs and Customer Obligations in the Ordinary Course of Business, and (II) Authorizing Banks to Honor and Process Checks and Electronic Transfer Requests Related Thereto Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: # 1 Exhibit A # 2 Exhibit B) (Califano, Thomas) | ||
| Apr 1 | 18 | Application to employ Kurtzman Carson Consultants LLC as Claims Agent Debtors' Emergency Application for Entry of an Order Authorizing the Retention and Employment of Kurtzman Carson Consultants LLC as Claims, Noticing, and Solicitation Agent, Effective as of the Petition Date Filed by Debtor Eiger BioPharmaceuticals, Inc. (Attachments: # 1 Exhibit A # 2 Exhibit B # 3 Exhibit C) (Califano, Thomas) | ||
| Apr 1 | 19 | Declaration re: Declaration of David Apelian in Support of the Chapter 11 Petitions and First Day Pleadings filed by Debtor Eiger BioPharmaceuticals, Inc. (RE: related document(s)1 Voluntary petition (chapter 11)). (Attachments: # 1 Exhibit A) (Califano, Thomas) | ||
| Apr 1 | 20 | Declaration re: Declaration of Paul Rundell, Managing Director of Alvarez & Marsal North America, LLC, in Support of the Debtors Emergency Motion for Entry of Interim and Final Orders (I) Authorizing the Debtors to Use Cash Collateral; (II) Granting Adequate Protection to Prepetition Term Loan Secured Parties; (III) Modifying Automatic Stay; and (IV) Scheduling a Final Hearing filed by Debtor Eiger BioPharmaceuticals, Inc. (RE: related document(s)16 Motion to use cash collateral Debtors' Emergency Motion for Entry of Interim and Final Orders (I) Authorizing the Debtors to Use Cash Collateral; (II) Granting Adequate Protection to Prepetition Term Loan Secured Parties; (III) Modifying Autom). (Califano, Thomas) | ||
There are 5 newer docket entries.To see the entire docket, login, subscribe now, or purchase this single case. |
||||
| Biorasi, LLC |
|---|
| Eiger InnoTherapeutics, Inc. |
| Eton Pharmaceuticals, Inc. |
| Internal Revenue Service |
| Jeffrey S. Glenn |
| Oracle America, Inc. |
| Progeria Research Foundation |
| State of Wisconsin Department of Health Services |
| Thermo Fisher Scientific |
Eiger BioPharmaceuticals, Inc.
2155 Park Boulevard
Palo Alto, CA 94306
SANTA CLARA-CA
Tax ID / EIN: xx-xxx1591
Thomas Robert Califano
Sidley Austin LLP
787 Seventh Avenue
New York, NY 10019
212-839-5575
Fax : 212-839-5599
Email: tom.califano@sidley.com
United States Trustee
1100 Commerce Street
Room 976
Dallas, TX 75202
214-767-8967
| Date Filed | Name = parent case |
Chapter | Case # |
|---|---|---|---|
| Apr 1 |
EB Pharma LLC
|
11 | 8:2024bk80042 |
| Apr 1 |
EBPI Merger Inc.
|
11 | 8:2024bk80041 |
| Jul 31, 2023 | Ariana, Inc | 7 | 5:2023bk50838 |
| Dec 29, 2022 | Aeldra Financial, Inc. | 7 | 3:2022bk30705 |
| Feb 18, 2021 | Andreas M. Kogelnik | 11 | 5:2021bk50203 |
| Jan 5, 2021 | zGlue, Inc. | 7 | 5:2021bk50017 |
| Mar 21, 2016 | Jumio Inc. | 11 | 1:16-bk-10682 |
| Oct 1, 2014 | Dean Lloyd, A Professional Law Corporation | 7 | 5:14-bk-54024 |
| Sep 4, 2014 | The Lawrence Company, LLC | 7 | 3:14-bk-31293 |
| Aug 6, 2013 | Q Builders, Inc. | 7 | 5:13-bk-54231 |
| Aug 6, 2013 | Omnia Alexis, LLC | 11 | 5:13-bk-54219 |
| Jul 25, 2012 | Fireear Inc. | 7 | 5:12-bk-55489 |
| Jun 27, 2012 | SZS Consulting Group LLC | 7 | 5:12-bk-54811 |
| Feb 22, 2012 | The Back Shop and Sleep Center, Inc. | 7 | 5:12-bk-51353 |
| Dec 15, 2011 | TeddyCrafters, Inc. | 7 | 5:11-bk-61417 |
